2-氨基-3-吡啶乙醇 | 954240-84-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-氨基-3-吡啶乙醇
• 英文名称: 2-(2-Aminopyridin-3-yl)ethanol
• CAS: 954240-84-7
• 化学式: C₇H₁₀N₂O
• 分子量: 138.17
• InChiKey: WXLBHOMNJPKFIF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  59.1
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• [EN] AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES<br/>[FR] IMIDAZOPYRIDAZINES AMINO-SUBSTITUÉES
  申请人：BAYER IP GMBH

  公开号：WO2013034570A1

  公开（公告）日：2013-03-14

  The present invention relates to amino-substituted imidazopyridazine compounds of general formula(I): in which A, R1, R3 and n are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

  本发明涉及一般式(I)的氨基取代咪唑吡啶化合物，其中A、R1、R3和n如权利要求中所定义，以及制备所述化合物的方法，包括含有所述化合物的药物组合物和配方，以及利用所述化合物制造用于治疗或预防疾病的药物组合物，特别是用作唯一药剂或与其他活性成分结合。
• AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES
  申请人：EIS Knut

  公开号：US20140296231A1

  公开（公告）日：2014-10-02

  The present invention relates to amino-substituted imidazopyridazine compounds of general formula (I): in which A, R1, R3 and n are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

  本发明涉及一般式（I）的氨基取代咪唑吡啶嗪化合物，其中A、R1、R3和n如权利要求中所定义，以制备上述化合物的方法，包括含有该化合物的制药组合物和药物组合物的制造用于治疗或预防疾病，特别是治疗或预防增生和/或血管生成障碍的制药组合物，作为唯一的药物或与其他活性成分联合使用。
• New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and intermediate products for their preparation
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0074653A2

  公开（公告）日：1983-03-23

  New cephem cumpounds of the formula: wherein R' is ammo or a protected amino group. R2 is lower aliphatic hydrocarbon group which may be substituted with suitable substituent(s), cylclopower)lalkyl or cyclo(lower)alkenyl; R3 defines certain subsituents, R4 is hydrogen or lower alkyl, and pharmaceutically acceptable salts thereof, processes for their preparation, and a pharmaceutrcal antibacterial composition comprising the above compound in associationwith a pharmaceutically acceptable substantially carrier or excipient.The Invention refers also to compounds of the formula

  式中的新头孢化合物： 式中 R' 是氨基或受保护的氨基。 R2 是可被适当取代基取代的低级脂肪烃基、环烷基或环（低级）烯基； R3 定义某些亚基、 R4 是氢或低级烷基，及其药学上可接受的盐、制备工艺，以及由上述化合物与药学上可接受的基本载体或赋形剂组成的药用抗菌组合物。
• MAR AND SCUFF RESISTANT POLYURETHANE COMPOSITION
  申请人：REICHHOLD CHEMICALS, INC.

  公开号：EP0748343A1

  公开（公告）日：1996-12-18
• PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSHORYLASE
  申请人：Prosidion Limited

  公开号：EP1636224A2

  公开（公告）日：2006-03-22